Literature DB >> 21198859

The 8p11 myeloproliferative syndrome owing to rare FGFR1OP2-FGFR1 fusion.

Masahiro Onozawa, Kazumasa Ohmura, Makoto Ibata, Junko Iwasaki, Kohei Okada, Ikumi Kasahara, Keisuke Yamaguchi, Kanako Kubota, Shinichi Fujisawa, Akio Shigematsu, Tomoyuki Endo, Takeshi Kondo, Satoshi Hashino, Junji Tanaka, Yoshihiro Matsuno, Masahiro Asaka, Masahiro Imamura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21198859     DOI： 10.1111/j.1600-0609.2010.01568.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  3 in total

1.  Systemic mastocytosis with associated myeloproliferative neoplasm with t(8;19)(p12;q13.1) and abnormality of FGFR1: report of a unique case.

Authors:  Christina B Duckworth; Linsheng Zhang; Shiyong Li
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

Review 2.  Acute myeloid leukemia associated with FGFR1 abnormalities.

Authors:  Hyeyoung Lee; Myungshin Kim; Jihyang Lim; Yonggoo Kim; Kyungja Han; Byung-Sik Cho; Hee-Je Kim
Journal:  Int J Hematol       Date:  2013-04-23       Impact factor: 2.490

3.  GZD824 overcomes FGFR1-V561F/M mutant resistance in vitro and in vivo.

Authors:  Kaili Jiang; Xia Tang; Jing Guo; Rui He; Shingpan Chan; Xiaojuan Song; Zhengchao Tu; Yuting Wang; Xiaomei Ren; Ke Ding; Zhang Zhang
Journal:  Cancer Med       Date:  2021-06-10       Impact factor: 4.452
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.